ASH1L and hepatocellular carcinoma: However, no significant difference was observed in the mutation frequency of the oncogenic RAS genes between the high and low ASH1L-AS1 expression groups, which is consistent with its relatively low mutation rate in HCC (approximately 3%) (Fig. S2C).